Biotech3 hours ago
Novo Nordisk: Stable Growth and Defensive Biotech Stock for DACH Investors in 2026
Novo Nordisk A/S (ISIN: DK0062498333) is a stable, growth-oriented biotech stock in 2026, driven by blockbuster drugs Ozempic and Wegovy. Dominating the diabetes and obesity markets,...